Skip to content

Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique

Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique: A Prospective Single Arm Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03375281
Enrollment
140
Registered
2017-12-18
Start date
2017-11-20
Completion date
2020-08-21
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma, Radiofrequency Ablation

Brief summary

The aim of this study is to evaluate clinical outcome of RFA for small single nodular HCC using no touch technique with separable clustered electrode (Octopus) in a prospective multicenter manner Participating center: Seoul national university hospital, Asan medical center, Samsung medical center, Kunkuk university hospital, St. mary's Seoul hospital

Interventions

PROCEDURERFA

thermal ablation using radiofrequency for HCC

Sponsors

Starmed
CollaboratorINDUSTRY
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Child-Pugh class A liver function * 1 - 2.5 cm sized Single nodular HCC * without history of previous HCC treatment or with evidence of no recurrence at least 2 years after previous HCC treatment

Exclusion criteria

* more than 2 HCC * tumor size larger than 2.5 cm * Child-Pugh class B or C liver function * invisible tumor even after real-time fusion US guidance * accompanied by vascular invasion or distant metastasis * presence of coagulopathy defined as platelet count \< 50,000/mm3 and/or PT-INR \> 50%

Design outcomes

Primary

MeasureTime frameDescription
1 year local tumor progression1 year after procedurecumulative incidence of local tumor progression after RFA

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026